Publications by authors named "Randall Rago"

Claim this Profile
P
Phase I study of a novel taxane BMS-188797 in adult patients with solid malignancies.
Christopher R Garrett, Mayer N Fishman, Randall R Rago, Charles C Williams, Anne M Dellaportas

Clin Cancer Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer.
Randall P Rago, Albert Einstein, Richard Lush, Tomasz M Beer, Yoo-Joung Ko

Cancer Chemother Pharmacol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480.
Eric J Small, Susan Halabi, Mark J Ratain, Gary Rosner, Walter Stadler, Randall Rago

J Clin Oncol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher doses of mitoxantrone among men with hormone-refractory prostate carcinoma: a Cancer and Leukemia Group B study.
Ellis G Levine, Susan Halabi, John D Roberts, Ellen B Kaplan, Randall Rago

Cancer· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis